Infection with the human papillomavirus (HPV), notably HPV type 16, has been associated with esophageal cancer in seroepidemiological studies.
To evaluate the consistency of the association, we performed a nested case-control study of HPV seropositivity and risk of esophageal cancer within a prospectively followed cohort of 300,000 Norwegian men and women who had donated blood samples to a serum bank.
The data file of the serum bank was linked with the nationwide Cancer Registry of Norway to identify esophageal cancers diagnosed after donation of the serum sample.
Fifty-seven cases and 171 matched controls were analyzed for antibodies to specific microorganisms, and odds ratios for developing esophageal cancer were calculated.
There was an increased risk of developing esophageal cancer among HPV 16-seropositive subjects (odds ratio=6.6 ; 95% confidence interval, 1.1-71) but not among Chlomydia trachomatis-seropositive subjects.
Adjustment for the presence of serum cotinine, a marker of smoking habits, did not affect the estimates substantially.
The seroepidemiological association between HPV 16 and esophageal cancer seems to be consistent in different countries.
Mots-clés Pascal : Tumeur maligne, Oesophage, Pathogénie, Facteur risque, Séropositivité, Papillomavirus humain 16, Papillomavirus, Papovaviridae, Virus, Epidémiologie, Homme, Appareil digestif pathologie, Oesophage pathologie, Norvège, Europe
Mots-clés Pascal anglais : Malignant tumor, Esophagus, Pathogenesis, Risk factor, Seropositivity, Human papillomavirus 16, Papillomavirus, Papovaviridae, Virus, Epidemiology, Human, Digestive diseases, Esophageal disease, Norway, Europe
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0520755
Code Inist : 002B13A01. Création : 13/02/1998.